Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2021
Home
2021
March 10, 2021
Published by
Dominic Burg
on
March 10, 2021
Categories
Commencement of the Trading of Rights on the ASX
March 10, 2021
Published by
Dominic Burg
on
March 10, 2021
Categories
Appendix 3B
March 10, 2021
Published by
Dominic Burg
on
March 10, 2021
Categories
Rights Issue Prospectus
March 10, 2021
Published by
Dominic Burg
on
March 10, 2021
Categories
Rights Issue
March 10, 2021
Published by
Dominic Burg
on
March 10, 2021
Categories
Pause in Trading
January 25, 2021
Published by
Dominic Burg
on
January 25, 2021
Categories
Appendix 4C and Quarterly Activity Report
January 25, 2021
Published by
Dominic Burg
on
January 25, 2021
Categories
Cellmid Receives First Order From Chinese Distributor
January 18, 2021
Published by
Dominic Burg
on
January 18, 2021
Categories
Appendix 2A
January 11, 2021
Published by
Dominic Burg
on
January 11, 2021
Categories
Final Director’s Interest Notice – King
Prev page
1
2
3
4
5
6
7
